Growth Metrics

Veon (VEON) EBITDA (2016 - 2025)

Veon has reported EBITDA over the past 15 years, most recently at $820.0 million for Q2 2025.

  • For Q2 2025, EBITDA rose 194.96% year-over-year to $820.0 million; the TTM value through Jun 2025 reached $1.8 billion, up 51.58%, while the annual FY2025 figure was $2.0 billion, 23.06% up from the prior year.
  • EBITDA was $820.0 million for Q2 2025 at Veon, up from $479.0 million in the prior quarter.
  • Across five years, EBITDA topped out at $876.0 million in Q1 2021 and bottomed at -$104.0 million in Q4 2021.
  • The 5-year median for EBITDA is $384.0 million (2021), against an average of $403.9 million.
  • Year-over-year, EBITDA tumbled 114.17% in 2021 and then skyrocketed 537.5% in 2022.
  • Over 5 years, EBITDA stood at -$104.0 million in 2021, then skyrocketed by 537.5% to $455.0 million in 2022, then crashed by 46.81% to $242.0 million in 2023, then surged by 97.93% to $479.0 million in 2024, then skyrocketed by 71.19% to $820.0 million in 2025.
  • The last three reported values for EBITDA were $820.0 million (Q2 2025), $479.0 million (Q4 2024), and $278.0 million (Q2 2024) per Business Quant data.